Vertex Global HC Fund II Pte. Ltd. - Jun 29, 2021 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role: 10%+ Owner
Signature: /s/ Wing Shing Lee, by power of attorney
Stock symbol: ELEV
Transactions as of: Jun 29, 2021
Transactions value $: $4,000,000
Form type: 4
Date filed: 6/29/2021, 04:07 PM
Previous filing: Jun 24, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELEV	Common Stock	Conversion of derivative security		+1.66M			1.66M	Jun 29, 2021	Direct	F1
transaction	ELEV	Common Stock	Conversion of derivative security		+401K	+24.21%		2.06M	Jun 29, 2021	Direct	F1
transaction	ELEV	Common Stock	Purchase	$4M	+250K	+12.15%	$16.00^*	2.31M	Jun 29, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELEV	Series A Convertible Preferred Stock	Conversion of derivative security		-7M	-100%		0	Jun 29, 2021	Common Stock	1.66M		Direct	F1
transaction	ELEV	Series B Convertible Preferred Stock	Conversion of derivative security		-1.69M	-100%		0	Jun 29, 2021	Common Stock	401K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock will automatically convert into Common Stock immediately on a 4.225582-for-one basis (4.225582 shares of preferred stock will convert into 1 share of Common Stock) prior to the closing of the Issuer's initial public offering, and has no expiration date.